Publications by authors named "Tamas Masszi"

100Publications

Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma.

Genes (Basel) 2020 Jul 13;11(7). Epub 2020 Jul 13.

MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/genes11070785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397208PMC
July 2020

[Epidemiology of early infections after autologous hematopoietic stem cell transplantation. ].

Orv Hetil 2020 Jan;161(3):103-109

Országos Hematológiai és Infektológiai Intézet, Hematológiai Osztály, Dél-pesti Centrumkórház Budapest, Albert Flórián út 5-7., 1097.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2020.31638DOI Listing
January 2020

Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance.

Cardiovasc Ultrasound 2019 Dec 26;17(1):32. Epub 2019 Dec 26.

3rd Department of Internal Medicine, Semmelweis University, Kútvölgyi 4, Budapest, 1125, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12947-019-0182-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933734PMC
December 2019

Identification of the best-suited donor for generating virus-specific T cells.

Vox Sang 2020 Jan 30;115(1):18-26. Epub 2019 Oct 30.

Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vox.12857DOI Listing
January 2020

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Lancet Haematol 2020 Jan 9;7(1):e28-e39. Epub 2019 Oct 9.

Department of Haematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland; Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026193015
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(19)30157-7DOI Listing
January 2020

Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation.

Bone Marrow Transplant 2020 01 16;55(1):215-223. Epub 2019 Sep 16.

Laboratory of Molecular Genetics, Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0656-4DOI Listing
January 2020

Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.

Pathology 2019 Apr 31;51(3):301-307. Epub 2018 Dec 31.

MTA-SE Momentum Molecular Oncohematology Research Group, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313025183038
Publisher Site
http://dx.doi.org/10.1016/j.pathol.2018.11.007DOI Listing
April 2019

[Systemic mastocytosis with progressive disease course].

Orv Hetil 2018 Feb;159(5):192-196

III. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Kútvölgyi út 4., 1125.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2018.30978DOI Listing
February 2018

Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.

Hum Immunol 2018 Jan 31;79(1):13-19. Epub 2017 Oct 31.

Department of Haematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest, Hungary; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2017.10.010DOI Listing
January 2018

[Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients. Three cases].

Orv Hetil 2017 Oct;158(41):1642-1648

III. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Kútvölgyi út 4., 1125.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2017.30873DOI Listing
October 2017

[Allogeneic hematopoietic stem cell transplantation in Hungary].

Orv Hetil 2017 Feb;158(8):291-297

III. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Üllői út 26., 1085; Budapest, Pf. 2, 1428.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2017.30648DOI Listing
February 2017

Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.

Pathol Oncol Res 2017 Jan 18;23(1):165-171. Epub 2016 Oct 18.

Department of Haematology and Stem Cell Transplantation, St. István and St László Hospital, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-016-0132-zDOI Listing
January 2017

[Chronic myelogenous leukemia: diagnosis and treatment].

Orv Hetil 2016 Sep;157(37):1459-68

III. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2016.30521DOI Listing
September 2016

Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

J Clin Oncol 2016 11;34(32):3921-3930

A. Keith Stewart, Mayo Clinic, Scottsdale, AZ; Meletios A. Dimopoulos, Alexandra Hospital, Athens, Greece; Tamás Masszi, St. István and St. László Hospital, Semmelweis University, Budapest, Hungary; Ivan Špička, General University Hospital in Prague, Prague; Roman Hájek, University Hospital Brno and University of Ostrava, Brno, Czech Republic; Albert Oriol, Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol; Laura Rosiñol, Hospital Clínic de Barcelona, Barcelona; Jesus F. San-Miguel, Clinica Universidad de Navarra/El Centro de Investigacíon Médica Aplicada, Instituto de Investigacíon Sanitaria de Navarra, Pamplona, Spain; David S. Siegel, John Theurer Cancer Center at Hackensack University, Hackensack, NJ; Ruben Niesvizky, Weill Cornell Medical College, New York, NY; Andrzej J. Jakubowiak, University of Chicago Medicine, Chicago, IL; Heinz Ludwig, Wilhelminen Cancer Research Institute, Wilheminenspital, Vienna, Austria; Jacqui Buchanan, Xinqun Yang, Biao Xing, Naseem Zojwalla, and Margaret Tonda, Onyx Pharmaceuticals, South San Francisco, CA; Kim Cocks, KCStats Consultancy, Leeds, United Kingdom; Philippe Moreau, University of Nantes, Nantes, France; and Antonio Palumbo, University of Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.9648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791840PMC
November 2016

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Aug;375(8):754-66

From the Department of Hematology, University of Turin, Turin, Italy (A.P.); the Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville (A.C.-K.); Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tuebingen (K.W.), and University Medical Center of the Johannes Gutenberg-University, Third Department of Medicine, Mainz (M.M.) - both in Germany; Winship Cancer Institute, Emory University, Atlanta (A.K.N.); the Department of Hematology and Stem Cell Transplantation, St. László Hospital, Semmelweis University, Budapest, Hungary (T.M.); Ankara University, Department of Hematology, Ankara, Turkey (M.B.); Clinical Department of Hematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic (I.S.); Irmandade Da Santa Casa De Misericordia De São Paulo, São Paulo (V.H.); University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain (M.V.M.); Weill Cornell Medical College, New York (T.M.M.); Janssen Research and Development, Spring House, PA (M.Q., X.Q., T.A.); Janssen Research and Development, Raritan, NJ (J.S., H.A.); Janssen Research and Development, Beerse, Belgium (W.D.); Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia (A.S.); and the Department of Hematology, Erasmus MC, Rotterdam, the Netherlands (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606038DOI Listing
August 2016

[Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report].

Orv Hetil 2016 Jun;157(23):916-8; quiz 919-20

Hematológiai és Őssejt-transzplantációs Osztály, Egyesített Szent István és Szent László Kórház Budapest.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2016.30430DOI Listing
June 2016

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Apr;374(17):1621-34

From University Hospital Hôtel Dieu, Nantes (P.M., C.T.), the Department of Hematology, Institut Paoli-Calmettes, Marseille (A.-M.S.), and the Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris (L.G.) - all in France; the Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary (T.M.); the Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, and St. John's Cancer Center, Lublin, Poland (N.G.); Southern Alberta Cancer Research Institute, University of Calgary, Calgary (N.J.B.), and the Division of Hematology, Department of Medicine, University of Alberta, Edmonton (I.S.) - both in Canada; the Department of Hematology, Skåne University Hospital, Lund University, Lund, Sweden (M.H.); Hematology and Oncology, University Hospital Brno, Brno, Czech Republic (L.P.); the Department of Haematology, Christchurch Hospital, Christchurch (P. Ganly), the Department of Haematology, Palmerston North Hospital, Palmerston North, Manawatu (B.W.B.), the Department of Haematology, Middlemore Hospital, Auckland (S.R.J.), and the Department of Haematology, North Shore Hospital, Auckland (D.R.S.) - all in New Zealand; the Department of Hematology, University Hospital Rigshospitalet, Copenhagen (P. Gimsing); Myeloma Unit, Division of Hematology, University of Turin, Turin (A.P.), and Seràgnoli Institute of Haematology, Bologna University School of Medicine, St. Orsola-Malpighi University Hospital, Bologna (M.C.) - both in Italy; the Division of Hematology, Mayo Clinic, Rochester, MN (S.K., F.K.B.); and Dana-Farber Cancer Institute, Boston (J.P.L., P.G.R.), and Millennium Pharmaceuticals, Cambridge (D.T.B., J.L., A.D.B., A.-M.H., H.V.) - both in Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1516282DOI Listing
April 2016

[Prognostic factors in light chain amyloidosis].

Orv Hetil 2015 Sep;156(39):1577-84

Egyesített Szent István és Szent László Kórház Budapest.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2015.30241DOI Listing
September 2015

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

J Clin Oncol 2015 Aug 22;33(23):2492-9. Epub 2015 Jun 22.

Owen A. O'Connor, Columbia University Medical Center; Steven Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY; Tamás Masszi, St Istvan and St Laszlo Hospital, Budapest, Hungary; Achiel Van Hoof, General Hospital St-Jan, Brugge, Belgium; Peter Brown, Rigshospitalet; Poul Knoblauch, Topotarget, Copenhagen, Denmark; Jeannette Doorduijn, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Wojciech Jurczak, Jagiellonian University, Krakow; Jan Walewski, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland; Shanta Chawla, Gajanan Bhat, Mi Rim Choi, and Lee F. Allen, Spectrum Pharmaceuticals, Irvine, CA; Kerry Savage, British Columbia Cancer Agency Centre, Vancouver, British Columbia, Canada; Francine Foss, Yale Cancer Center, New Haven, CT; and Andrei Shustov, University of Washington Medical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.2782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087312PMC
August 2015

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.

J Clin Oncol 2015 Apr 2;33(11):1252-7. Epub 2015 Mar 2.

Richard M. Stone, Emanuele Mazzola, and Donna Neuberg, Dana-Farber Cancer Institute, Boston; Ante S. Lundberg, Antisoma, Cambridge, MA; Steven L. Allen, Hofstra North Shore-Long Island Jewish School of Medicine, Lake Success; Meir Wetzler, Roswell Park Cancer Institute, Buffalo; Martin S. Tallman, Memorial Sloan Kettering Cancer Center, New York, NY; Arnaud Pigneux, Hopital Haut-Leveque, Pessac, France; Robert K. Stuart, Medical University of South Carolina, Charleston, SC; David Rizzieri, Duke University Medical Center, Durham; Bayard Powell, Wake Forest University Comprehensive Cancer Center, Winston Salem, NC; Harry P. Erba, University of Michigan Health System, Ann Arbor, MI; Lloyd Damon, University of California San Francisco, San Francisco, CA; Jun-Ho Jang, Samsung Medical Center, Seoul, Korea; Krzysztof Warzocha, Institute of Hematology and Transfusiology, Warsaw, Poland; Támas Masszi, Szent Istvan and Szent Laszlo Corporate Hospital, Budapest; Miklos Egyed, Kaposi Mor County Teaching Hospital, Kasposvar, Hungary; Mikkael A. Sekeres, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Heinz-August Horst, Universitatsklinikum Schleswig-Holstein, Kiel, Germany; Dominik Selleslag, Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium; Scott R. Solomon, Blood and Marrow Transplant Program and Northside Hospital, Atlanta, GA; and Parameswaran Venugopal, Rush University Medical Center, Chicago, IL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/26/JCO.2014.57
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.0952
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.0952DOI Listing
April 2015

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

N Engl J Med 2015 Jan;372(5):426-35

From Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence (A.M.V.), Ospedale di Circolo e Fondazione Macchi, Varese (F. Passamonti), and University of Naples Federico II, Naples (F. Pane) - all in Italy; Hôpital Saint-Louis et Université Paris Diderot, Paris (J.J.K.); Johannes Wesling Clinic, Minden, Germany (M.G.); St. István and St. László Hospital and Semmelweis University, Budapest, Hungary (T.M.); Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia (S.D.); Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.); Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium (P.Z.); Mayo Clinic Cancer Center, Scottsdale, AZ (R.M.); Incyte, Wilmington, DE (S.H., M.M.J., W.G.); Novartis Pharmaceuticals, East Hanover, NJ (J.L., D.H.); Novartis Pharma, Basel, Switzerland (U.P.); and University of Texas M.D. Anderson Cancer Center, Houston (S.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1409002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358820PMC
January 2015

[Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms].

Orv Hetil 2014 Dec;155(52):2074-81

Országos Vérellátó Szolgálat Molekuláris Diagnosztikai Laboratórium Budapest Karolina út 19-21. 1113.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/OH.2014.30051DOI Listing
December 2014

NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma.

Br J Haematol 2015 Mar 3;168(5):679-88. Epub 2014 Nov 3.

3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13197DOI Listing
March 2015

[How long does a myeloma patient currently wait for the diagnosis in Hungary?].

Orv Hetil 2014 Sep;155(39):1538-43

Semmelweis Egyetem, Általános Orvostudományi Kar III. Belgyógyászati Klinika Budapest Kútvölgyi út 4. 1125 Egyesített Szent István és Szent László Kórház-Rendelőintézet Hematológiai és Őssejt-transzplantációs Osztály Budapest.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/OH.2014.30000DOI Listing
September 2014

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

Haematologica 2014 Jul 3;99(7):1184-90. Epub 2014 Jun 3.

Department of Hematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.107482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077079PMC
July 2014

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.

J Clin Oncol 2013 Oct 26;31(28):3549-56. Epub 2013 Aug 26.

Arnon Nagler and Avichai Shimoni, Chaim Sheba Medical Center, Tel Hasomer, Israel; Vanderson Rocha, Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom; Myriam Labopin and Mohamad Mohty, Hôpital Saint-Antoine, Paris University; Gerard Socie, Hôpital St Louis, Paris; Mauricette Michallet, Hôpital Edouard Herriot, Lyon; Ibrahim Yakoub-Agha, University Hospital Lille, France; Ali Unal, Erciyes Medical School, Kayseri, Turkey; Tarek Ben Othman, Centre National de Greffe de Moelle, Tunis, Tunisia; Antonio Campos, Instituto Portugues de Oncologia do Porto, Porto, Portugal; Liisa Volin, Helsinki University Central Hospital, Helsinki, Finland; Xavier Poire, Cliniques Universitaires St Luc, Brussels, Belgium; Mahmoud Aljurf, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Tamás Masszi, St Istvan and St Laszlo Hospital, Budapest, Hungary; Henrik Sengelov, National University Hospital, Copenhagen, Denmark; Jakob Passweg, University Hospital, Basel, Switzerland; and Hendrik Veelken, Leiden University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.48.8114DOI Listing
October 2013

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation.

Eur J Haematol 2013 Aug 28;91(2):135-40. Epub 2013 Jun 28.

1st Department of Psychiatry and Psychiatric Rehabilitation, Jahn Ferenc Hospital, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12126DOI Listing
August 2013

Characterization and function of histamine receptors in human bone marrow stromal cells.

Stem Cells 2012 Feb;30(2):222-31

National Institutes of Dental and Craniofacial Research, Craniofacial and Skeletal Diseases Branch, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138060PMC
February 2012

Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.

Med Oncol 2012 Sep 30;29(3):2136-42. Epub 2011 Oct 30.

Laboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Karolina str 19-21, Budapest 1113, Hungary.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12032-011-0092
Web Search
http://link.springer.com/10.1007/s12032-011-0092-9
Publisher Site
http://dx.doi.org/10.1007/s12032-011-0092-9DOI Listing
September 2012

[Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].

Orv Hetil 2011 Jul;152(27):1063-7

Fővárosi Önkormányzat Egyesített Szent István és Szent László Kórház-Rendelőintézet (ESZSZK) I. Belgyógyászat-Hematológiai Osztály Budapest Gyáli út 5-7. 1097.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/OH.2011.29150DOI Listing
July 2011

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.

Am J Hematol 2011 Jul 14;86(7):550-3. Epub 2011 Jun 14.

Department of Hematology, Oncology and Internal Diseases, The Medical University of Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22038DOI Listing
July 2011

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.

Leuk Lymphoma 2011 Sep 12;52(9):1711-9. Epub 2011 Jun 12.

Department of Hematology, Oncology and Internal Diseases, The Medical University of Warsaw, Warsaw, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.578312DOI Listing
September 2011

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma.

Int J Hematol 2011 Apr 1;93(4):545-550. Epub 2011 Mar 1.

PET-CT Medical, Diagnostic Ltd., Laky Adolf u. 44-46, Budapest, 1145, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-011-0795-xDOI Listing
April 2011

Analyses of donor-derived keratinocytes in hairy and nonhairy skin biopsies of female patients following allogeneic male bone marrow transplantation.

Stem Cells Dev 2012 Jan 17;21(1):152-7. Epub 2011 Mar 17.

Craniofacial and Skeletal Diseases Branch, National Institutes of Dental and Craniofacial Research, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/scd.2010.0593
Publisher Site
http://dx.doi.org/10.1089/scd.2010.0593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245666PMC
January 2012

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.

Exp Hematol 2010 Dec 15;38(12):1219-30. Epub 2010 Sep 15.

Department of Microbiology, Tumor and Cell Biology and Center for Integrative Recognition in the Immune System, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2010.09.001DOI Listing
December 2010

Serum beta2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults.

Clin Chem Lab Med 2009 ;47(5):585-9

Department of Haematology and Stem Cell Transplantation, St. László Hospital, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2009.137DOI Listing
August 2009